Article Versions Notes

Hering NA, Günzler E, Arndt M, Zibell M, Lauscher JC, Kreis ME, Beyer K, Seeliger H, Pozios I. Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer. Cancers. 2023; 15(2):456. https://doi.org/10.3390/cancers15020456

Hering, Nina A., Emily Günzler, Marco Arndt, Miriam Zibell, Johannes C. Lauscher, Martin E. Kreis, Katharina Beyer, Hendrik Seeliger, and Ioannis Pozios. 2023. "Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer" Cancers 15, no. 2: 456. https://doi.org/10.3390/cancers15020456

Hering, N. A., Günzler, E., Arndt, M., Zibell, M., Lauscher, J. C., Kreis, M. E., Beyer, K., Seeliger, H., & Pozios, I. (2023). Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer. Cancers, 15(2), 456. https://doi.org/10.3390/cancers15020456